http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3562482-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e62fd9f84126bd5865aa2c900af00f90 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-336 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-336 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate | 2017-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20006e61aa3dda087b2f0acce26b287f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48cd3e608bc0a5a4ef4648e7fdd6cb95 |
| publicationDate | 2019-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-3562482-A1 |
| titleOfInvention | Variants of 2-[6-(4-chlorophenoxy)hexyl]-oxirane-2-carboxylic acid for use in the treatment, prevention and/or amelioration of brain diseases |
| abstract | The present invention relates to 2-[6-(4-chlorophenoxy)hexyl]-oxirane-2-carboxylic acid for use in the treatment, prevention and/or amelioration of disorders caused by delipidation of neural tissue. Specific aspects relate to certain administration or dosing patterns, routes of administration. In one embodiment of the present invention is the invention Multiple Sclerosis (MS) or an MS associated disease. |
| priorityDate | 2016-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 328.